Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
High-Dose Intravenous Vitamin C (IVC) is a method of delivering vitamin C directly into the bloodstream through an IV. This allows much higher levels of vitamin C in the blood than taking vitamin C by mouth, which is limited by how much the gut can absorb. Sometimes called pharmacologic ascorbate, IVC is discussed in cancer care mainly as a nutrition or supportive therapy rather than a standard cancer treatment.
People with cancer often face challenges such as poor nutrition, inflammation, changes in immune function, and side effects from treatments like chemotherapy or radiation. IVC is sometimes considered to help support these areas, aiming to improve overall well-being and help patients better tolerate their cancer treatments. Some alternative health communities promote IVC as a direct cancer treatment, but strong scientific evidence supporting these claims is limited or mixed. It is important to understand that IVC is not a proven cure or replacement for standard cancer therapies.
Patients may encounter IVC mentioned in medical records, treatment plans, or discussions about nutrition and supportive care. It might also appear in research articles, videos, or alternative health sources. The term can be listed as High-Dose Intravenous Vitamin C, IVC, or pharmacologic ascorbate. Because it is not FDA-approved as a cancer treatment, patients should be cautious about claims of cure or tumor shrinkage and understand that IVC is often described as a supportive or experimental approach.
Receiving IVC does not mean a patient is getting a proven cancer cure or that standard treatments like chemotherapy, radiation, surgery, or immunotherapy are being replaced. Some people mistakenly believe that high-dose vitamin C can detoxify the body or repair DNA, but these claims are not supported by strong evidence. It is important to separate hopeful or experimental uses from proven therapies to avoid misunderstandings.
While vitamin C is generally safe in normal amounts, high-dose intravenous vitamin C can have risks, especially for people with certain health conditions such as kidney problems, glucose-6-phosphate dehydrogenase (G6PD) deficiency, or hemochromatosis. It may also interact with some chemotherapy drugs and affect lab tests. Because cancer patients often have complex health needs, any use of IVC should be discussed with healthcare providers who know the patient’s full medical history and current treatments. This helps ensure safety and appropriate monitoring.
If you see High-Dose Intravenous Vitamin C mentioned in your care or hear about it from other sources, the best step is to ask your healthcare team what it means for your specific situation. They can explain whether it is part of your treatment plan, supportive care, or an experimental approach, and help you understand any potential benefits, risks, or interactions with your other treatments.